Dr. David Nathanson is a professor of molecular and medical pharmacology at UCLA. He received his Ph.D. in molecular and medical pharmacology at UCLA under Dr. Paul Mischel, where he discovered that ...
A key outcome from lung cancer screening studies is the concept of ‘stage-shift’ seen in screen-detected cancers compared ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果